• intent@hq.icmr.org.in

Existing gaps

  • India with 18% of the global population conducts only 1·4% of global clinical trials.
  • Regulatory clinical trial capacity traditionally exist with pharmaceutical industry and CROs.
  • Individuals are frequently sceptic to participate.
  • Academic centres lack critical capacity in areas such as regulatory compliance, data management, etc. and restrict themselves to Non-regulatory trials.

Phase-II/III Trial Centers

Zoomable Image

# Institute Details
52 Jawaharlal Institute of Medical Education & research (JIPMER), Puducherry
53 St. John’s Medical College, Bengaluru, Karnataka
54 Amrita Institute of Medical Sciences, Kochi, Kerala
55 LV Prasad Eye Institute, Hyderabad, Telangana
56 Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamilnadu
57 Christian Medical College, Vellore, Tamil Nadu
58 Yenepoya Medical College Hospital, Mangalore, Karnataka
59 ICMR-National Institute of Traditional Medicine, Belagavi, Karnataka
60 JSS Academy of Higher Education and Research, Mysuru, Karnataka
61 Kasturba Medical College, Manipal, Karnataka
62 Chettinad Hospital and Research Institute, Chengalpattu, Tamil Nadu
63 Gandhi Medical College, Secunderabad, Telangana
64 Tirunelveli Medical College, Tirunelveli, Tamil Nadu
65 Karnataka Institute of Medical Sciences, Hubli, Karnataka
66 Pondicherry Institute of Medical Sciences, Puducherry
67 DM Wayanad Medical College, Wayanad, Kerala
68 Narayana Medical College & Hospital, Nellore
69 Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research, Belagavi, Karnataka
70 SRM Medical College Hospital & Research Centre, Chennai, Tamil Nadu
71 National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu
72 National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka
73 Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum
74 The George Institute of Public Health, Hyderabad, Telangana
75 Mahatma Gandhi Medical College and Research Institute, Puducherry

Phase-II/III Sites

# Institute Lead Co-ordinator
53 Jawaharlal Institute of Medical Education & research (JIPMER), Puducherry Dr Sandhiya Selvarajan
54 St Johns Medical College, Bengaluru, Karnataka Dr Denis Xavier
55 Amrita Institute of Medical Sciences, Kochi, Kerala Dr Jaideep Menon
56 LV parsad eye institute, Hyderabad, Telangana Dr Raja Narayanan
57 Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamilnadu Dr S.Nagendra Boopathy
58 Christian Medical College, Vellore, Tamil Nadu Dr Jacob John
59 Yenepoya Medical College Hospital, Yenepoya (Deemed to be University) City, Mangalore, Karnataka Dr Prabha Adhikari MR
60 ICMR-National Institute of Traditional Medicine, Belagavi, Karnataka Dr Manish Barvaliya
61 JSS Academy of Higher Education and Research, Mysuru, Karnataka Dr Basavana Gowdappa Hathur
62 Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka Dr Chythra R. Rao
63 Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education,Chengalpattu, Chennai, Tamilnadu Dr R. Arunkumar
64 Gandhi Medical College, Secunderabad, Telangana Dr Thrilok Chander
65 Tirunelveli Medical College, Tirunelveli, Tamil Nadu Dr Shantararaman.K.
66 Karnataka Institute of Medical Sciences, Hubli, Karnataka Dr Ram S. Kaulgud
67 Pondicherry Institute of Medical Sciences, Puducherry Dr Anil J Purty
68 DM Wayanad Medical College, Waynad, Kerala Dr Aneesh Basheer
69 Narayana Medical College & Hospital, Nellore Dr Coordinator Name
70 Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research Belagavi, Karnataka Dr Shivaprasad S Goudar
71 SRM Medical College Hospital & Research Centre, Chennai, Tamil Nadu Dr Melvin George
72 National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu Dr C.Padmapriyadarsini
73 National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka Dr Sriganesh K
74 Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum Dr Jeemon Panniyammakal
75 The George Institute of Public Health, Hyderabad, Telangana Prof. Vivekanand Jha

Expected outcomes

  • Build capacity of investigators through training and collaboration.
  • Improve capability to conduct academic as well as regulatory clinical trials.
  • Improve the clinical trial ecosystem by trial methodology research, frequent interaction with stakeholders, regulatory research etc.
  • Improve representation of the diverse Indian community.
  • Instil confidence in Indian study participants through transparency and advocacy.
  • Identify and support a plug-and-play clinical trial network that can readily evaluate health products that are of national health priority.
  • Conduct large decisive trials, in areas of National Health Priorities.
  • Clinical development of indigenous drugs, vaccines, devices and diagnostics.
  • Provide evidence-based, cost effective, scientifically sound and culturally sensitive solutions to problems.
  • Influence health policies and practices.